Get the Stockscreener App
1.28
8.47%
0.10
After Hours:
1.35
0.07
+5.47%
Mindwalk Holdings Corp stock is traded at $1.28, with a volume of 334.80K.
It is up +8.47% in the last 24 hours and up +3.23% over the past month.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
See More
Previous Close:
$1.18
Open:
$1.14
24h Volume:
334.80K
Relative Volume:
0.75
Market Cap:
$59.79M
Revenue:
$13.18M
Net Income/Loss:
$-9.65M
P/E Ratio:
-6.7227
EPS:
-0.1904
Net Cash Flow:
$-8.58M
1W Performance:
+14.29%
1M Performance:
+3.23%
6M Performance:
-25.15%
1Y Performance:
+0.00%
1-Day Range:
$1.14
$1.309
1-Week Range:
$1.06
$1.309
52-Week Range:
$0.99
$2.99
Mindwalk Holdings Corp Stock (HYFT) Company Profile
Compare HYFT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HYFT
Mindwalk Holdings Corp
|
1.28 | 55.12M | 13.18M | -9.65M | -8.58M | -0.1904 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Oct-25-21 | Initiated | The Benchmark Company | Buy |
Mindwalk Holdings Corp Stock (HYFT) Latest News
HYFT: MindWalk Holdings Corp.Insider Transations - Zacks Investment Research
MindWalk Holdings (HYFT) price target decreased by 25.00% to 3.06 - MSN
HYFT Options Volatility — NASDAQ:HYFT - TradingView — Track All Markets
HYFT Options Chain — NASDAQ:HYFT - TradingView — Track All Markets
HYFT Forecast, Price Target & Analyst Ratings | MINDWALK HOLDINGS CORP (NASDAQ:HYFT) - ChartMill
HYFT PE Ratio & Valuation, Is HYFT Overvalued - Intellectia AI
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) Q3 2026 earnings call transcript - MSN
MindWalk Holdings Corp. (HYFT) reports Q3 loss, lags revenue estimates - MSN
MindWalk Holdings Corp (TQB0.MU) Insider Ownership & Holdings - Yahoo! Finance Canada
MindWalk Holdings Reports March Insider Share Purchases and RSU Positions - TipRanks
Top MindWalk (HYFT) Competitors 2026 - MarketBeat
HYFT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
MindWalk (NASDAQ: HYFT) insiders add shares and report major RSU grants - Stock Titan
Purchase/sale of business (net) of MindWalk Holdings Corp. – NASDAQ:HYFT - TradingView
MindWalk Holdings Discloses March Insider Share Purchases in Voluntary U.S. Filing - TipRanks
MindWalk (NASDAQ: IPA) insiders add 60,000 shares in March 2026 buys - Stock Titan
Durchbruch: Nie mehr Grippe durch LensAI™-Entdeckung?! - Wallstreet Online
Mindwalk Holdings: Zusammenarbeit mit Pfizer, Roche, Merck, Bayer…?! - Wallstreet Online
Mindwalk Holdings: Mit 19 der größten 20 Big-Pharma-Player „im Bett“ - wallstreet-online.de
Benchmark reiterates Speculative Buy on MindWalk Holdings stock By Investing.com - Investing.com Canada
Benchmark reiterates Speculative Buy on MindWalk Holdings stock - Investing.com
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2026 Earnings Call Transcript - Insider Monkey
H.C. Wainwright reiterates Buy on MindWalk stock on SaaS deal - Investing.com Nigeria
H.C. Wainwright reiterates Buy on MindWalk stock on SaaS deal By Investing.com - Investing.com India
MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts By GuruFocus - Investing.com Canada
MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts - GuruFocus
MindWalk (HYFT) Q3 2026 Earnings Call Transcript - AOL.com
MindWalk Holdings Corp. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:HYFT) 2026-03-12 - Seeking Alpha
MindWalk Holdings Corp. Q3 2026 Earnings Call Summary - Yahoo Finance
HYFT: Q3 revenue up 52% YoY, recurring LensAI contract signed, and pipeline programs advanced - TradingView
MindWalk Holdings Corp. (HYFT) Posts Third Quarter Loss, Falls Short of Revenue Expectations - Bitget
HYFT: Q3 FY 2026 revenue rose 52% YoY, with first enterprise contract and $14.2M cash on hand - TradingView
Q3 2026 MindWalk Holdings Corp Earnings Call Transcript - GuruFocus
MindWalk Holdings Corp. (HYFT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
MindWalk Holdings Corp reports results for the quarter ended January 31Earnings Summary - TradingView
MindWalk Holdings Files Q3 2026 MD&A and Interim Financials - TipRanks
HYFT: Q3 revenue up 52% to $4.2M, with recurring contracts and pipeline progress boosting outlook - TradingView
MindWalk Holdings (NASDAQ: IPA) grows revenue 45% and boosts margins amid AI pivot - Stock Titan
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results - The Joplin Globe
MindWalk Holdings Corp. (Nasdaq: HYFT) posts 52% Q3 revenue growth - Stock Titan
MindWalk Holdings emphasizes AI-driven strategy in latest financial release - MSN
MindWalk Holdings Corp PE Ratio (TTM) & PE Ratio (TTM) ChartsHYFT - GuruFocus
MindWalk launches nanobody discovery platform for bispecifics - Investing.com Nigeria
MindWalk Holdings Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
MindWalk launches nanobody discovery platform for bispecifics By Investing.com - Investing.com Australia
Mindwalk Holdings Corp Stock (HYFT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):